Ablation of FABP5 led to a mild increase in systemic insulin sensitivity in genetic and dietary obesity mouse models [39], whereas adipose tissue-specific overexpression of FABP5 in transgenic mice resulted in a reduction in systemic insulin sensitivity in a high-fat diet model [39]. The gene discussed is INS; the disease is Obesity.